This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.
Hello! It’s so damn hot. 😥
advertisement
Apologies for the delay in delivery this morning, but I wanted to include a Novartis-pelabresib update from its earnings announcement. It’s the lead item below.
STAT+ Exclusive Story
Already have an account? Log in
Get unlimited access to award-winning journalism and exclusive events.